PDCD4 and melanoma: There was a trend towards improved 5-year survival in primary melanomas with high nuclear PDCD4, Figure 2b (log-rank test p = 0.085; RR 0.914; Lower CL 0.803; Upper CL 0.998, p = 0.043).